Odomos and the Outdoor Protection Battle

Industry & Competitive Context

India's household insecticide market is large and format-fragmented, spanning coils, vaporizers/liquid electric machines, mats, aerosols, and personal application products (creams, lotions, gels, sprays, patches, and roll-ons). Industry estimates compiled in trade and brand presentations placed the broader insecticide market at roughly Rs 1,600–2,400 crore in the early 2010s, with coils and vaporizers commanding the largest format shares, while the personal-application cream segment was comparatively small — estimated at around Rs 50–98 crore in a Dabur-commissioned brand review of the category. A market overview within that period described the total category as roughly Rs 98 crore, growing at a CAGR of about 1.25%, with Odomos positioned as the dominant player but losing ground to other formats and facing low consumer acceptance. Within personal application repellents specifically, Dabur Odomos held an estimated 85% share, well ahead of leading brands in other formats such as Goodknight in coils (33%) and mats (55%) and All-Out in vaporizers (69%). This made Odomos's strategic problem distinctive relative to its competitive set: rather than fighting for share within a format, its central challenge was expanding the personal-application format itself relative to room-based alternatives such as coils, mats, and vaporizers, which dominate indoor usage occasions. Globally and in India, the competitive set for outdoor and personal mosquito protection includes multinational and domestic players. A 2026 industry report on the global mosquito repellent market identifies Godrej Consumer Products, Dabur India, Spectrum Brands Holdings, Reckitt Benckiser, and S.C. Johnson and Son as the major companies operating in the category, with the same report noting that creams, lotions, and roll-ons are the preferred format for parents seeking controlled application for children, with Dabur's Odomos cream leading India's topical market. Public health context has materially shaped the category's marketing logic: the same report states that in 2024, India recorded 285,296 dengue cases with 190 deaths, and in 2023 the country logged 1.6 million malaria cases, underscoring why outdoor, daytime protection — rather than only night-time indoor protection — has become a central battleground for brand communication.

Brand Situation Prior to Campaign Activity

Odomos's modern brand history is tied closely to Dabur's acquisition strategy. In January 2005, Dabur India announced the acquisition of Balsara Hygiene Products, Balsara Home Products, and Besta Cosmetics, gaining access to oral care brands Babool and Meswak alongside household brands including Odonil, Odopic, Sanifresh, and Odomos. At the time of acquisition, Odomos contributed roughly Rs 230 million in turnover within the acquired Balsara portfolio and held a dominant share in the personal application insect repellent market. Following the acquisition, Dabur invested in expanding the brand's format range. According to brand reporting in Business Standard, Dabur launched the Odomos spray in 2008 and an Odomos fabric roll-on in 2020, building out a portfolio that, per Dabur's own brand page, today includes cream, lotion, spray, gel, patches, and roll-on formats designed for effective protection. Despite this format expansion, brand commentary from 2019 in Business Standard observed that Odomos faced the structural challenge of an near-generic, category-defining heritage product needing to "reimagine itself" for a new generation of consumers and a more crowded shelf, while Dabur sought to reposition it from a household staple into a lifestyle purchase available across multiple price points, supported by more frequent advertising. A recurring strategic problem documented across brand materials is consumer indifference to mosquito-borne risk specifically in outdoor and daytime contexts. A Dabur Odomos brand campaign document explicitly frames the challenge as increasing usage of the repellent during outdoor activities while addressing consumer indifference to mosquito threats, within a competitive market where brand differentiation was needed. This is consistent with messaging repeated across multiple Odomos press releases, which consistently work to correct a public misconception that mosquito-borne disease risk is confined to evenings or indoor settings.

Strategic Objective

Across the publicly documented campaign cycles — spanning the early "Zero Tolerance Against Mosquitoes" initiative, the "Machchar" social seeding campaign, and the recurring multi-year "#MakingIndiaDengueFree" platform — Odomos's stated strategic objectives are consistent and explicitly disclosed in company press releases and campaign materials:

First, to reposition daytime and outdoor protection as a distinct, underserved need, separate from the night-time, indoor protection associated with coils and vaporizers. Dabur's own brand page states this directly: conventional mosquito repellents such as liquid vaporizers, mats, and coils offer protection only within the closed confines of a room, whereas Odomos's personal application range offers protection both inside the house and outdoors, where the risk of disease-carrying mosquito bites is described as high.

Second, to convert awareness of dengue and malaria risk into habitual product trial, particularly among parents of school-going children and outdoor workers/commuters. A six-month campaign blueprint described in Odomos brand campaign materials explicitly sought to increase outdoor usage occasions, elevate dengue awareness, position Odomos as the preferred outdoor protection option, and drive trial and habitual usage among target demographics.

Third, to use public-health messaging as a brand equity platform, linking the commercial brand to a social mission. This is stated verbatim in Dabur's press materials for the recurring #MakingIndiaDengueFree initiative, which describes itself as part of Odomos's "mission to help fight mosquito-borne diseases."

Campaign Architecture & Execution

Odomos's outdoor protection messaging has been executed through several distinct, publicly documented initiatives over more than a decade, rather than a single unified campaign. Four are well attributed in public sources.

Zero Tolerance Against Mosquitoes (2013). This initiative combined a school-outreach and competition format with category education. Dabur's press release describes a new advanced Odomos formula designed to mask the distinctive body odour emitted by human skin so that mosquitoes cannot detect the wearer, alongside messaging contrasting room-based repellents with Odomos's claimed indoor-and-outdoor protection. The release also notes Odomos's safety credentials, stating it was certified safe for use on infants and children in a test conducted by leading paediatricians, per Dr. S.V. Devasthale, then Head of R&D (Home Care) at Dabur's Research & Development Centre. The campaign incorporated a school-level competition soliciting information on mosquito-breeding-prevention measures taken by schools.

Dedicated website and digital "Machchar" seeding campaign (2013). Documented in a 2013 Newswire release and a contemporaneous Odomos brand-campaign presentation, this phase combined a dedicated educational website with a multi-channel digital seeding push. Dabur launched a one-stop website for Odomos aimed at answering consumer questions on mosquito protection and providing tips to safeguard families against dengue and malaria, framed against a backdrop of rising viral infection rates in India. In parallel, brand campaign materials describe a structured six-month rollout combining news seeding in the press, advertorials and native content on health and parenting websites and digital newspaper editions, a "@Machhar" Twitter handle personifying the mosquito as an antagonist character, a website launch, online contests, and participation in the "Happy Streets" on-ground event property. The Machhar handle specifically was used as a content device: it was introduced to spread its "terror" among Twitter users, hosting conversations about where the mosquito had been biting people, how it scouts and selects targets, and various "mosquito myths," over a three-to-four week period.

Format expansion supported by youth-targeted creative (2019). As Odomos pushed the convenience-oriented spray format, Dabur produced a long-format digital film titled "Kids Vs Mosquito Rap Battle." Per afaqs! reporting, Odomos spray, introduced in 2008, was the subject of a minute-long rap-battle-style communication designed to bring alive the campaign line "Odomos nahi pehna to ghar pe rehna" (loosely, "if you haven't worn Odomos, stay home") and to connect with children and new-age mothers, prompting Dabur to move beyond the standard 30-second television commercial format. Industry commentary on the execution, also reported by afaqs!, characterized the strategic intent as addressing parental anxiety about protecting children from mosquito-borne disease while overcoming children's resistance to applying protective creams, with the rap-battle device communicating that the new spray was a precondition for moving freely in the outdoors.

#MakingIndiaDengueFree (multi-year, 2021–2025). This is Odomos's most extensively documented and longest-running public outdoor-protection initiative, executed as a series of city- and state-level activations rather than a single national campaign. The initiative was first announced in Lucknow on 18 October 2021, described by Dabur as starting in Uttar Pradesh, with a stated reach target of 5 lakh people across 52 cities, combining education on dengue risk with distribution of free Odomos mosquito repellent cream and awareness sessions conducted in public areas such as bus terminals and railway stations. A subsequent phase was launched in Meerut on 12 October 2022, this time targeting outreach to around 20 lakh people across 70 towns in Uttar Pradesh, again pairing dengue/malaria education with distribution of free Odomos samples. A further phase activated in Kolkata paired the campaign with public-facing awareness camps; per coverage republished from a PTI press release, the Kolkata activation was framed by Vaibhav Rathi, then Marketing Head–Home Care at Dabur India, around the need to increase awareness of outdoor protection both for children and for office-goers, given that dengue- and malaria-causing mosquitoes bite primarily during the day rather than at night.

Cricket-stadium activation (2025). The most recent documented outdoor execution shifted the channel from city/town outreach to large live-sporting-event activation. Per a PTI press release carried by multiple outlets including The Tribune and The Wire, Odomos executed a campaign outside cricket stadiums in Delhi and Bangalore, distributing Odomos mosquito repellent to cricket fans between 1 pm and 6 pm on match days so that they could watch matches without being bitten, reinforcing the brand's commitment to making India dengue-free. Odomos brand ambassadors distributed over 20,000 sachets at stadium entry points during this window, and attendees also received application tips and basic hygiene guidance, such as draining stagnant water around seating areas after rainfall to reduce mosquito breeding. Santosh Jayswal, identified in the release as Category Head for Homecare at Dabur, was quoted explaining the timing rationale around early monsoon conditions increasing mosquito activity ahead of matches.

Positioning & Consumer Insight

The consistent consumer insight underlying all five documented initiatives is a perceptual gap: Indian consumers commonly associate mosquito risk, and therefore mosquito protection, with evenings and indoor settings — the occasions served by coils, mats, and vaporizers — while underestimating risk during daytime outdoor activity, which is when Aedes mosquitoes (the dengue vector) are most active. Dabur's press materials repeatedly and explicitly correct this misconception rather than treating it as implicit subtext. A 2021 Odomos press release states plainly that dengue-spreading mosquitoes primarily bite during daytime, and that children are at risk not only while playing outdoors but also inside their own rooms. The 2025 Kolkata activation repeated this framing nearly verbatim, with Marketing Head Vaibhav Rathi noting that contrary to popular perception, dengue and malaria are spread by daytime mosquitoes, putting children and office commuters at risk both outdoors and inside enclosed spaces. This positioning serves a clear category-expansion function: by reframing "outdoor protection" as a distinct, daily-use occasion rather than an occasional travel or camping need, Odomos sought to grow the addressable use-case base for personal-application repellents beyond their historically small share of the broader insecticide market, rather than competing for share purely within the existing personal-application segment where it already held a dominant position. The brand's right-to-win claim is built on two recurring proof points across press materials: a mechanism story (the odour-masking formulation that makes the wearer effectively undetectable to mosquitoes, as described in the 2013 Zero Tolerance release) and a medical-endorsement signal (paediatrician safety testing for infants and children, and endorsement by the National Integrated Medical Association as stated on Dabur's official Odomos brand page). Both elements function to de-risk the personal-application format for parents, who are consistently positioned in the brand's communications as the primary purchase decision-maker.

Media & Channel Strategy

Public sources document a deliberate shift in channel mix over time, moving from press-led category education toward integrated digital seeding, and subsequently toward large-scale on-ground/experiential activation tied to public-health messaging. The 2013 phase combined earned and paid press placements (news seeding and advertorials in health, parenting, and general news outlets), digital partnerships (described in campaign materials as including a "Chief Digital Media Partner" providing event coverage, native content, and a co-branded dengue report), social media (the @Machhar Twitter handle as a branded-character content engine), and experiential/on-ground presence via association with the "Happy Streets" event property, according to the Odomos brand campaign presentation.

The #MakingIndiaDengueFree platform (2021–2025) relies primarily on on-ground public outreach — direct distribution of free product samples, awareness camps, and activations in high-footfall public infrastructure such as bus terminals and railway stations — rather than mass broadcast advertising, based on the consistent description across Dabur's own press releases for the Lucknow, Meerut, and Kolkata phases. The most recent disclosed execution (2025) extends this on-ground logic to live sporting events, distributing product directly at cricket stadium entry points in Delhi and Bangalore during defined match-day hours, per the PTI release. No verified public information is available on paid media weights, GRP/TRP figures, specific media agency mandates, or precise budget allocations for any of these Odomos campaign phases; none of the cited sources disclose spend figures.

Business & Brand Outcomes

Quantified outcomes specific to the outdoor-protection campaigns themselves are limited in public disclosure; what is available comes primarily from category-level reach figures stated in press releases and aggregate brand performance disclosed in Dabur's investor communications, rather than campaign-attributed sales or awareness lift metrics.

Reach figures:

• The October 2021 #MakingIndiaDengueFree launch phase targeted direct outreach to 5 lakh (500,000) people across 52 cities in Uttar Pradesh.

• The October 2022 phase targeted direct outreach to approximately 20 lakh (2 million) people across 70 towns in Uttar Pradesh.

• The 2025 cricket-stadium activation distributed more than 20,000 sachets at stadium entry points in Delhi and Bangalore during the specified match-day windows.

  
  

These are reach/distribution targets and counts as stated by the company; no independent third-party verification of actual achieved reach was found in available public sources, and no source discloses campaign-attributed sales lift, market share change, or brand-awareness survey results tied specifically to these outdoor-protection initiatives.

Brand-level performance (from equity research notes citing Dabur's investor disclosures, not campaign-specific): Sell-side research notes summarizing Dabur's quarterly disclosures provide category-level, not campaign-specific, performance context. One note covering a quarter ending February 2023 reported that Dabur's Home Care category grew 18.2% with a three-year CAGR of 11.5%, led by double-digit growth for Odonil, Odomos, and Sanifresh, with Odomos recording a 200 basis-point market share gain during that quarter. More recently, a Q4 FY26 update reported that Odomos was among the brands driving volume-led growth for Dabur's domestic India business, with the company stating that the majority of its portfolio continued to outpace category growth and was expected to register market share gains during the quarter. These figures reflect overall brand performance within Dabur's reporting segments and cannot be directly attributed to the outdoor-protection campaigns described above, since Dabur's public disclosures do not isolate campaign-level financial or share impact.

Strategic Implications

Three patterns emerge from the publicly documented record of Odomos's outdoor-protection marketing that are useful for classroom discussion of category and brand strategy.

First, Odomos's marketing problem is a category-expansion problem disguised as a market-share problem. Despite commanding a dominant position within personal application repellents — an estimated 85% share of that format as of the early-2010s brand review — the brand's growth ceiling was set by the small absolute size of that format relative to coils, mats, and vaporizers. The recurring strategic response, across more than a decade of campaigns, has been to grow the occasion (daytime, outdoor use) rather than to fight over an already-dominated segment, illustrating a classic category-captain strategy: invest in expanding the category pie rather than defending share within a static category.

Second, the brand has consistently used public-health framing as a structural element of brand strategy, not as corporate social responsibility bolted onto a separate marketing program. The #MakingIndiaDengueFree platform's repeated, near-identical messaging across 2021, 2022, and 2025 phases — correcting the daytime-mosquito misconception, distributing free product, and engaging in public-infrastructure outreach — suggests this is treated as a durable, long-running brand platform rather than a one-off seasonal promotion, consistent with how the brand's own materials describe it as tied to a "mission."

Third, the channel evolution from press/digital seeding (2013) to direct on-ground sampling tied to high-footfall public moments (2021–2025) reflects a broader, evidenced shift in Indian FMCG marketing away from awareness-only campaigns toward outcome-oriented activations that combine education with immediate trial (free sample distribution at the point of need — stadiums, transit hubs, monsoon-season public spaces). This is consistent with the brand's stated objective, as far back as 2013, of converting awareness into "product trials and habitual usage," suggesting a long-term strategic continuity in objective even as tactics and channels have changed substantially.

A limitation for any analysis of this case is that Odomos/Dabur's public disclosures consistently report reach targets and distribution counts but do not publish campaign-attributed business outcomes (sales lift, share shift, ROI). This is a structural constraint common to FMCG marketing case research generally: brand-level financial disclosures (via quarterly investor updates) and campaign-level execution disclosures (via press releases) are reported through separate channels and are not reconciled by the company in public filings.

Discussion Questions

1. Odomos held an estimated 85% share within the personal-application repellent format, yet that format represented only a small fraction of the total household insecticide market dominated by coils and vaporizers. How should a brand strategist distinguish between a "share problem" and a "category size problem," and what does Odomos's response over the past decade suggest about which one it diagnosed?

   
   

2. The #MakingIndiaDengueFree platform has been re-launched in similar form across at least three documented phases (2021, 2022, 2025) in different cities, each time repeating the same core insight (daytime mosquito risk). What are the strategic advantages and risks of running a long-duration, repeated public-health platform versus rotating to fresh creative campaigns each year?

   
   

3. Odomos's channel strategy visibly shifted from digital/press seeding (2013) toward direct on-ground product sampling at high-footfall public moments such as cricket stadiums and transit hubs (2021–2025). What underlying assumption about the Indian outdoor-protection consumer might explain this shift, and what trade-offs does sampling-led activation involve relative to mass broadcast advertising?

   
   

4. Public disclosures for this case consist of company press releases (reach targets, distribution counts) and separate, non-campaign-specific investor disclosures (category growth, market share basis-point changes). What are the limitations of evaluating marketing campaign effectiveness when a company does not publicly reconcile these two types of disclosure, and what additional data would an analyst need to draw a causal link between campaign activity and brand performance?

   
   

5. Odomos's positioning rests on correcting a stated consumer misconception — that mosquito-borne disease risk is primarily a night-time, indoor phenomenon. If this insight has been the core of the brand's messaging since at least 2013, what does the persistence of this same corrective framing across more than a decade of campaigns suggest about either the durability of the misconception or the limits of public-health messaging in shifting deeply held consumer beliefs?